From: Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
P value
Hazard ratio
95% CI
Performance status
0.1
2.098
0.867 - 5.073
Tumor response
0.002
0.43
0.253 - 0.732
Second-line chemotherapy
0.573
0.855
0.495 - 1.476